Sierra Oncology (NASDAQ:SRRA) Earnings Information
Sierra Oncology last released its earnings results on November 4th, 2019. The biotechnology company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.21) by $0.04. Sierra Oncology has generated ($0.75) earnings per share over the last year. Sierra Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2020 based off prior year's report dates.
Sierra Oncology Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Sierra Oncology (NASDAQ:SRRA) Earnings Estimates
2019 EPS Consensus Estimate: ($0.85)
2020 EPS Consensus Estimate: ($0.62)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2019 | 2 | ($0.21) | ($0.21) | ($0.21) |
| Q2 2019 | 2 | ($0.21) | ($0.19) | ($0.20) |
| Q3 2019 | 3 | ($0.25) | ($0.21) | ($0.23) |
| Q4 2019 | 3 | ($0.28) | ($0.15) | ($0.21) |
| Q1 2020 | 1 | ($0.20) | ($0.20) | ($0.20) |
| Q2 2020 | 1 | ($0.14) | ($0.14) | ($0.14) |
| Q3 2020 | 1 | ($0.14) | ($0.14) | ($0.14) |
| Q4 2020 | 1 | ($0.14) | ($0.14) | ($0.14) |
Sierra Oncology (NASDAQ SRRA) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | GAAP EPS | Revenue Estimate | Actual Revenue | Conference Call | Details |
|---|
2/27/2020
(Estimated) | | | | | | | | |
| 11/4/2019 | Q3 | ($0.21) | ($0.17) | ($0.17) | | | N/A | |
| 8/8/2019 | Q2 | ($0.1970) | ($0.20) | ($0.20) | | | N/A | |
| 5/8/2019 | 3/31/2019 | ($0.21) | ($0.17) | ($0.17) | | | N/A | |
| 2/28/2019 | Q4 2018 | ($0.21) | ($0.19) | ($0.19) | | | N/A | |
| 11/8/2018 | 9/30/2018 | ($0.18) | ($0.21) | ($0.21) | | | N/A | |
| 8/9/2018 | 6/30/2018 | ($0.16) | ($0.16) | ($0.16) | | | N/A | |
| 5/10/2018 | Q1 | ($0.21) | ($0.19) | ($0.19) | | | N/A | |
| 2/27/2018 | Not Specified | ($0.22) | ($0.20) | ($0.20) | | | N/A | |
| 11/8/2017 | Q3 2017 | ($0.21) | ($0.19) | ($0.19) | | | N/A | |
| 8/10/2017 | 6/30/2017 | ($0.21) | ($0.20) | ($0.20) | | | N/A | |
| 5/9/2017 | 3/31/2017 | ($0.19) | ($0.26) | ($0.26) | | | N/A | |
| 3/2/2017 | Q4 2016 | ($0.29) | ($0.30) | ($0.30) | | | N/A | |
| 11/10/2016 | Q3 2016 | ($0.30) | ($0.50) | ($0.50) | | | N/A | |
| 8/12/2016 | Q2 2016 | ($0.38) | ($0.43) | ($0.43) | | | N/A | |
| 5/10/2016 | Q1 2016 | ($0.42) | ($0.35) | ($0.35) | | | N/A | |
| 3/3/2016 | Q4 2015 | ($0.55) | ($0.38) | ($0.38) | | | N/A | |
| 11/5/2015 | Q3 2015 | ($0.49) | ($10.72) | ($10.41) | | | N/A | |
| 8/21/2015 | Q2 2015 | ($6.19) | ($98.35) | ($92.60) | | | N/A | |
(Earnings results data provided by Zacks Investment Research)
